Advertisement

AAPS PharmSciTech

, Volume 19, Issue 4, pp 1672–1680 | Cite as

Nanoparticles for Protein Sensing in Primary Containers: Interaction Analysis and Application

  • Víctor Pérez Medina Martínez
  • Carlos E. Espinosa-de la Garza
  • Diego A. Méndez-Silva
  • Mariana Bolívar-Vichido
  • Luis F. Flores-Ortiz
  • Néstor O. PérezEmail author
Research Article

Abstract

Silver nanoparticles (AgNPs) are known to interact with proteins, leading to modifications of the plasmonic absorption that can be used to monitor this interaction, entailing a promising application for sensing adsorption of therapeutic proteins in primary containers. First, transmission electron microscopy in combination with plasmonic absorption and light scattering responses were used to characterize AgNPs and protein-AgNP complexes, including its concentration dependence, using two therapeutic molecules as models: a monoclonal antibody (mAb) and a synthetic copolymer (SC). Upon interaction, a protein corona was formed around AgNPs with the consequent shifting and broadening of their characteristic surface plasmon resonance (SPR) band (400 nm) to 410 nm and longer wavelenghts. Additional studies revealed secondary and three-dimensional structure modifications of model proteins upon interaction with AgNPs by circular dichroism and fluorescence techniques, respectively. Based on the modification of the SPR condition of AgNPs upon interaction with proteins, we developed a novel protein-sensing application of AgNPs in primary containers. This strategy was used to conduct a compatibility assessment of model proteins towards five commercially available prefillable glass syringe (PFS) models. mAb- and SC-exposed PFSs showed that 74 and 94% of cases were positive for protein adsorption, respectively. Interestingly, protein adsorption on 15% of total tested PFSs was negligible (below the nanogram level). Our results highlight the need of a case-by-case compatibility assessment of therapeutic proteins and their primary containers. This strategy has the potential to be easily applied on other containers and implemented during early-stage product development by pharmaceutical companies and for routine use during batch release by packaging manufacturers.

KEY WORDS

Monoclonal antibody Prefilled syringes Primary container Silver nanoparticles Synthetic copolymer 

Notes

Funding Information

This work was supported by CONACYT, Mexico (grant PEI CONACYT 2015 220333). CONACYT did not participate in the design of the study or in the collection, analysis, and interpretation of data.

References

  1. 1.
    Vivek M, Kumar PS, Steffi S, Sudha S. Biogenic silver nanoparticles by Gelidiella acerosa extract and their antifungal effects. Avicenna J Med Biotechnol. 2011;3:143–8.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Haes AJ, Van Duyne RP. A nanoscale optical biosensor: sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles. J Am Chem Soc. 2002;124:10596–604.  https://doi.org/10.1021/ja020393x.CrossRefPubMedGoogle Scholar
  3. 3.
    Rasmussen PE, Jayawardene I, Gardner HD, Chénier M, Levesque C, Niu J. Single molecule applications of quantum dots. JPCS. 2013;4:27–42.  https://doi.org/10.4236/jmp.2013.411A2002.Google Scholar
  4. 4.
    Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh SS. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf B. 2010;77:240–5.  https://doi.org/10.1016/j.colsurfb.2010.01.033.CrossRefGoogle Scholar
  5. 5.
    Babu A, Templeton AK, Munshi A, Ramesh R. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer. AAPS PharmSciTech. 2014;15:709–21.  https://doi.org/10.1208/s12249-014-0089-8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev. 2011;111:5610–37.  https://doi.org/10.1021/cr100440g.CrossRefPubMedGoogle Scholar
  7. 7.
    Garcia MA. Surface plasmons in metallic nanoparticles: fundamentals and applications. J Phys D Appl Phys. 2011;4:1–20.  https://doi.org/10.1088/0022-3727/44/28/283001.Google Scholar
  8. 8.
    Lee KS, El-Sayed MA. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B. 2006;110:19220–5.  https://doi.org/10.1021/jp062536y.CrossRefPubMedGoogle Scholar
  9. 9.
    Mahmoudi M, Monopoli MP, Rezaei M. The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation. Chembiochem. 2013;14:568–72.  https://doi.org/10.1002/cbic.201300007.CrossRefPubMedGoogle Scholar
  10. 10.
    Blunk T, Hochstrasser DF, Sanchez JC, Müller BW, Müller RH. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1993;14:1382–7.  https://doi.org/10.1002/elps.11501401214.CrossRefPubMedGoogle Scholar
  11. 11.
    Jia G, Cao Z, Xue H, Xu Y, Jiang S. Novel zwitterionic-polymer-coated silica nanoparticles. Langmuir. 2009;25:3196–9.  https://doi.org/10.1021/la803737c.CrossRefPubMedGoogle Scholar
  12. 12.
    Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M. Nanoparticle and protein corona. In: Martinac B, editor. Protein-nanoparticle interactions. Berlin: Springer; 2013. p. 21–44.CrossRefGoogle Scholar
  13. 13.
    Rumyantsev KA, Shemetov AA, Nabiev IR, Sukhanova AV. Structural and functional aspects of the interaction of proteins and peptides with nanoparticles. Nanotechnol Russ. 2013;8:700–20.  https://doi.org/10.1134/S1995078013060116.CrossRefGoogle Scholar
  14. 14.
    US Food and Drug Administration. Guidance for industry—container closure systems for packaging human drugs and biologics. Chemistry manufacturing and controls documentation. US Food and Drug Administration, Rockville. 1999. http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070551. Accessed 15 Nov 2017.
  15. 15.
    Gerhardt A, Mcgraw NR, Schwartz DK, Bee JS, Carpenter JF, Randolph TW. Protein aggregation and particle formation in prefilled glass syringes. J Pharm Sci. 2014;103:1601–12.  https://doi.org/10.1002/jps.23973.CrossRefPubMedGoogle Scholar
  16. 16.
    Gay AJ, Goldor H, Smith M. Chorioretinal vascular occlusions with latex spheres. Investig Ophthalmol Vis Sci. 1964;3:647–56.Google Scholar
  17. 17.
    Sacha AG, Safell-Clemmer W, Abram K, Akers MJ. Practical fundamentals of glass, rubber, and plastic sterile packaging systems. Pharm Dev Technol. 2010;15:6–34.  https://doi.org/10.3109/10837450903511178.CrossRefPubMedGoogle Scholar
  18. 18.
    Badkar A, Wolf A, Bohack L, Kolhe P. Development of biotechnology products in pre-filled syringes: technical considerations and approaches. AAPS PharmSciTech. 2011;12:564–72.  https://doi.org/10.1208/s12249-011-9617-y.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
  20. 20.
    Espinosa-de la Garza CE, Miranda-Hernández MP, Acosta-Flores L, Pérez NO, Flores-Ortiz LF, Medina-Rivero E. Analysis of therapeutic proteins and peptides using multiangle light scattering coupled to ultra high performance liquid chromatography. J Sep Science. 2015;38:1537–43.  https://doi.org/10.1002/jssc.201400863.CrossRefGoogle Scholar
  21. 21.
    Mulfinger L, Solomon SD, Bahadory M, Jeyarajasingam AV, Rutkowsky SA, Boritz CJ. Synthesis and study of silver nanoparticles. Chem Educ. 2007;84:322–5.  https://doi.org/10.1021/ed084p322.CrossRefGoogle Scholar
  22. 22.
    Kayser V, Chennamsetty N, Voynov V, Helk B, Trout BL. Tryptophan-tryptophan energy transfer and classification of tryptophan residues in proteins using a therapeutic monoclonal antibody as a model. J Fluoresc. 2011;21:275–88.  https://doi.org/10.1007/s10895-010-0715-0.CrossRefPubMedGoogle Scholar
  23. 23.
    Bindhu MR, Umadevi M. Silver and gold nanoparticles for sensor and antibacterial applications. SAA. 2014;128:37–45.  https://doi.org/10.1016/j.saa.2014.02.119.Google Scholar
  24. 24.
    Ding F, Radic S, Chen R, Chen P, Geitner NK, Brown JM, et al. Direct observation of a single nanoparticle-ubiquitin corona formation. Nano. 2013;5:9162–9.  https://doi.org/10.1039/c3nr02147e.Google Scholar
  25. 25.
    Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010;4:3623–32.  https://doi.org/10.1021/nn901372t.CrossRefPubMedGoogle Scholar
  26. 26.
    Podila R, Chen R, Ke PC, Brown JM, Rao AM. Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett. 2012;101:1–4.  https://doi.org/10.1063/1.4772509.Google Scholar
  27. 27.
    Amendola V, Bakr OM, Stellacci F. A study of the surface plasmon resonance of silver nanoparticles by the discrete dipole approximation method: effect of shape, size, structure, and assembly. Plasmonics. 2010;5:85–97.  https://doi.org/10.1007/s11468-009-9120-4.CrossRefGoogle Scholar
  28. 28.
    Ahamed M, Posgai R, Gorey TJ, Nielsen M, Hussain SM, Rowe JJ. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol Appl Pharmacol. 2010;242:263–9.  https://doi.org/10.1016/j.taap.2009.10.016.CrossRefPubMedGoogle Scholar
  29. 29.
    Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M. Analytical methods for corona evaluations. In: Martinac B, editor. Protein-nanoparticle interactions. Berlin: Springer; 2013. p. 65–82.CrossRefGoogle Scholar
  30. 30.
    Rabe M, Verdes D, Seeger S. Surface-induced spreading phenomenon of protein clusters. Soft Matter. 2009;5:1039–47.  https://doi.org/10.1039/B814053G.CrossRefGoogle Scholar
  31. 31.
    Rahman DS, Deb S, Ghosh SK. Relativity of electron and energy transfer contributions in nanoparticle-induced fluorescence quenching. J Phys Chem C. 2015;119:27145–55.  https://doi.org/10.1021/acs.jpcc.5b08466.CrossRefGoogle Scholar
  32. 32.
    Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017;46:D1074–82.  https://doi.org/10.1093/nar/gkx1037.CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Scheffler K, Damoc E, Müller M, Zeller M, Moehring T. Improving intact antibody characterization by orbitrap mass spectrometry. Dreieich and Bremen (Germany): Thermo Fisher Scientific; 2013. Poster No.: PN63712.Google Scholar
  34. 34.
    Chen J, Toptygin D, Brand L, King J. Mechanism of the efficient tryptophan fluorescence quenching in human gammaD-crystallin studied by time-resolved fluorescence. Biochemistry. 2008;47:10705–21.  https://doi.org/10.1021/bi800499k.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Pan H, Qin M, Meng W, Cao Y, Wang W. How do proteins unfold upon adsorption on nanoparticle surfaces? Langmuir. 2012;28:12779–87.  https://doi.org/10.1021/la302258k.CrossRefPubMedGoogle Scholar
  36. 36.
    Monopoli MP, Walczyk D, Campbell A. Physical-chemical aspects of protein corona: relevance to in vitro and in vitro biological impacts of nanoparticles. J Am Chem Soc. 2011;133:2525–34.  https://doi.org/10.1021/ja107583h.CrossRefPubMedGoogle Scholar
  37. 37.
    Yoshino K, Nakamura K, Yamashita A, Abe Y, Iwasaki K, Kanazawa Y, et al. Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system. J Pharm Sci. 2014;103:1520–8.  https://doi.org/10.1002/jps.23945.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Tovey MG, Lallemand C. Immunogenicity and other problems associated with the use of biopharmaceuticals. Ther Adv Drug Saf. 2011;2:113–28.  https://doi.org/10.1177/2042098611406318.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Rathore N, Pranay P, Eu B, Ji W, Walls E. Variability in syringe components and its impact on functionality of delivery systems. PDA J Pharm Sci Tech. 2011;65:468–80.  https://doi.org/10.5731/pdajpst.2011.00785.CrossRefGoogle Scholar
  40. 40.
    Krayukhina E, Tsumoto K, Uchiyama S, Fukui K. Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins. J Pharm Sci. 2015;104:527–35.  https://doi.org/10.1002/jps.24184.CrossRefPubMedGoogle Scholar
  41. 41.
    Ludwig DB, Carpenter JF, Hamel JB, Randolph TW. Protein adsorption and excipient effects on kinetic stability of silicones oil emulsions. J Pharm Sci. 2010;99:1721–33.  https://doi.org/10.1002/jps.21982.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Víctor Pérez Medina Martínez
    • 1
  • Carlos E. Espinosa-de la Garza
    • 1
  • Diego A. Méndez-Silva
    • 1
    • 2
  • Mariana Bolívar-Vichido
    • 1
  • Luis F. Flores-Ortiz
    • 1
  • Néstor O. Pérez
    • 1
    Email author
  1. 1.Unidad de Investigación y DesarrolloProbiomed, S.A. de C.VTenancingoMéxico
  2. 2.Departamento de Ingeniería en NanotecnologíaUniversidad de La Ciénega del Estado de Michoacán de OcampoSahuayoMéxico

Personalised recommendations